sacubitril/valsartan
Showing 26 - 50 of 410
Myocardial Infarction, Hypertension Trial in Qingdao (Sacubitril/Valsartan 49/51mg/Tab, Valsartan 80mg/Tab)
Not yet recruiting
- Myocardial Infarction
- Hypertension
- Sacubitril/Valsartan 49/51mg/Tab
- Valsartan 80mg/Tab
-
Qingdao, Shandong, ChinaMengmei Li
Sep 18, 2021
Heart Failure Trial in Turku (sacubitril/valsatran, valsartan, to valsartan)
Recruiting
- Heart Failure
- sacubitril/valsatran
- +3 more
-
Turku, FinlandNovartis Investigative Site
Dec 2, 2021
Obesity, Cardiovascular Diseases, Hypertension Trial in Birmingham (Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet, Valsartan 80
Recruiting
- Obesity
- +5 more
- Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet
- Valsartan 80 mg Oral Tablet
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jun 6, 2022
Compare Hospitalization Between Naive Sacubitril/Valsartan and
Completed
- Heart Failure
- Sacubitril/valsartan
- ACEi/ARB
-
East Hanover, New JerseyNovartis Investigative Site
Dec 15, 2021
Aortic Valve Insufficiency Trial in Seoul (Sacubitril-valsartan, Amlodipine-losartan)
Recruiting
- Aortic Valve Insufficiency
-
Seoul, Korea, Republic ofSamsung Medical Center
Jan 27, 2022
STEMI Trial in Chengdu (Sacubitril-Valsartan, Enalapril, Valsartan)
Not yet recruiting
- STEMI
- Sacubitril-Valsartan
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital
Sep 23, 2021
Heart Failure, Systolic Trial in Seoul (Sacubitril-Valsartan, Valsartan)
Recruiting
- Heart Failure, Systolic
-
Seoul, Korea, Republic ofSamsung Medical Center
Aug 17, 2021
Hypertension, Left Ventricular Hypertrophy Trial in Shanghai (sacubitril/valsartan, Amlodipine)
Recruiting
- Hypertension
- Left Ventricular Hypertrophy
- sacubitril/valsartan
- Amlodipine
-
Shanghai, ChinaShanghai Institite of Hypertension, Ruijin Hospital, Shanghai Ji
Dec 7, 2021
Heart Failure With Preserved Ejection Fraction, Chronic Kidney Diseases Trial in Rochester (MANP, Sacubitril/Valsartan, Oral
Enrolling by invitation
- Heart Failure With Preserved Ejection Fraction
- Chronic Kidney Diseases
- MANP
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 22, 2022
Heart Failure With Reduced Ejection Fraction Patients Treated
Completed
- Heart Failure
- Sacubitril/Valsartan
-
Trieste, ItalyNovartis Investigative Site
Nov 7, 2022
Heart Failure Trial (Placebo, XXB750 Low dose, XXB750 Medium Dose)
Not yet recruiting
- Heart Failure
- Placebo
- +4 more
- (no location specified)
Nov 24, 2023
PreDiabetes, Impaired Glucose Tolerance, Obesity Trial in Columbus (Sacubitril-Valsartan Tab 97-103 MG, Valsartan 160mg, Placebo
Recruiting
- PreDiabetes
- +3 more
- Sacubitril-Valsartan Tab 97-103 MG
- +2 more
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Jul 21, 2022
Heart Failure Trial in Saga (Sacubitril Valsartan Sodium Hydrate, Standard treatment)
Recruiting
- Heart Failure
- Sacubitril Valsartan Sodium Hydrate
- Standard treatment
-
Saga, JapanSaga University Hospital
Dec 27, 2021
Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors
Not yet recruiting
- Aortic Valve Stenosis
- Angiotensin Receptor-Neprilysin Inhibitor
- antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 4, 2023
Cardio-Renal Syndrome Trial in Qingdao (Roxadustat;Sacubitril Valsartan Sodium Tablets;, EPO; ACEI / ARB)
Recruiting
- Cardio-Renal Syndrome
- Roxadustat;Sacubitril Valsartan Sodium Tablets;
- EPO; ACEI / ARB
-
Qingdao, Shangdong, ChinaDepartment of Nephrology, Affiliated Hospital of Qingdao Univers
Sep 13, 2021
Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Sacubitril-valsartan
- SGLT2 inhibitor
-
Porto, Portugal
- +3 more
Aug 9, 2023
Hypotension, Heart Failure Trial in Taipei (Dapagliflozin, Sacubitril-Valsartan, Beta blocker)
Completed
- Hypotension
- Heart Failure
- Dapagliflozin
- +4 more
-
Taipei, TaiwanCheng Hsin General Hospital
Jul 27, 2021
Heart Failure With Preserved Ejection Fraction Trial (Sacubitril-Valsartan)
Withdrawn
- Heart Failure With Preserved Ejection Fraction
- (no location specified)
Aug 24, 2021
Entresto on Left Ventricular Remodelling on Cardiac MRI
Recruiting
- Heart Failure With Reduced Ejection Fraction
- Additional Cardiac Magnetic Resonance Scan
-
Southampton, Hampshire, United KingdomUniversity Hospital Southampton NHS Foundation Trust
Apr 26, 2022
Acute Myocardial Infarction Trial in Alexandria (Sacubitril / Valsartan Oral Tablet [Entresto])
Recruiting
- Acute Myocardial Infarction
- Sacubitril / Valsartan Oral Tablet [Entresto]
-
Alexandria, EgyptAndalusia Hospitals
May 28, 2021
Heart Failure With Reduced Ejection Fraction Trial in Leipzig, Kaiserslautern (Sacubitril-Valsartan)
Active, not recruiting
- Heart Failure With Reduced Ejection Fraction
-
Leipzig, Saxony, Germany
- +1 more
Dec 28, 2021
Chronic Heart Failure, Sleep Apnea Syndrome Trial in France (SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®))
Completed
- Chronic Heart Failure
- Sleep Apnea Syndrome
- SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®)
-
Bordeaux, Pessac, France
- +5 more
Jun 10, 2021
Systemic Right Ventricle, Heart Failure Trial in Montreal (Sacubitril / Valsartan Oral Tablet, Placebo)
Active, not recruiting
- Systemic Right Ventricle
- Heart Failure
- Sacubitril / Valsartan Oral Tablet
- Placebo
-
Montreal, Quebec, CanadaMontreal Heart Institute
Dec 21, 2022